Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» IPOs
IPOs
Adaptive Biotechnologies Updates IPO Filing – Will Raise Up To $327 Million
CP Wire
Wed, 06/26/19 - 10:04 am
Adaptive Biotechnologies
IPOs
cancer
In $86M IPO pitch, Mirum spells out plans to turn Shire discards into orphan liver drug successes
Endpoints
Mon, 06/24/19 - 11:14 am
Mirum
IPOs
Shire
liver disease
Genetic Disease Focused Fulcrum Therapeutics Files for $86 Million IPO
CP Wire
Mon, 06/24/19 - 09:32 am
Fulcrum Therapeutics
IPOs
FSHD
sickle cell disease
beta thalassemia
Genetic Disease Focused Fulcrum Therapeutics Files for $86 Million IPO
Mon, 06/24/19 - 09:29 am
Fulcrum Therapeutics
IPOs
FSHD
sickle cell disease
beta thalassemia
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Readouts And IPOs
Yahoo/Benzinga
Sun, 06/23/19 - 02:04 pm
Merck
Keytruda
Melinta Therapeutics
Amag Pharmaceuticals
Palatin
Acer Therapeutics
Sanofi
Regeneron
Alexion
Pfizer
Roche
Navidea Biopharmaceuticals
Ascendis Pharma
Scholar Rock
Adaptive Biotechnologies
BridgeBio
IPOs
G Medical Innovations
Karuna
Morphic Therapeutics
Four More Through the IPO Door as Life Science Firms Raise $465M
Xconomy
Thu, 06/20/19 - 11:48 am
IPOs
Personalis
Akero Therapeutics
Prevail Therapeutics
Atreca
Stoke Therapeutics Upsizes IPO, Raises $142M for Dravet Drug R&D
Xconomy
Tue, 06/18/19 - 11:35 pm
Stoke Therapeutics
IPOs
Dravet syndrome
Karuna Therapeutics Raises Its IPO Estimate to $85 Million
CP Wire
Mon, 06/17/19 - 12:22 pm
Karuna Therapeutics
IPOs
schizophrenia
Alzheimer's disease
The Week Ahead In Biotech: Conferences, PDUFA Dates Clinical Trial Readouts And IPOs
Yahoo/Benzinga
Sun, 06/16/19 - 05:41 pm
FDA
Merck
Arqule
Affimed
BeiGene
Epizyme
MorphoSys
Theravance
Allena Pharma
Akero Therapeutics
Atreca
Dermavant Sciences
Personalis
Prevail Therapeutics
Stoke Therapeutics
IPOs
Change Healthcare Updates Filing for $1.2 Billion IPO and Equity Offering
CP Wire
Fri, 06/14/19 - 10:00 am
Change Healthcare
McKesson
IPOs
Ramaswamy's Dermavant Updates $124 Million IPO Filing
CP Wire
Mon, 06/10/19 - 09:53 am
Dermavant
IPOs
tapinarof
psoriasis
dermatitis
Vivek Ramaswamy
Ramaswamy's Dermavant Updates $124 Million IPO Filing
Mon, 06/10/19 - 09:46 am
Dermavant
tapinarof
psoriasis
dermatitis
IPOs
Personalis Updates $122 Million IPO Filing
CP Wire
Fri, 06/7/19 - 12:05 pm
Perosnalis
IPOs
immuno-oncology
Personalis Updates $122 Million IPO Filing
Fri, 06/7/19 - 11:02 am
Perosnalis
IPOs
Inhibrx Files for $75 Million IPO
CP Wire
Tue, 06/4/19 - 10:57 am
Inhibrx
IPOs
Inhibrx Files for $75 Million IPO
Tue, 06/4/19 - 02:35 pm
Inhibrx
IPOs
Adaptive Biotechnologies Files for $230 Million IPO
CP Wire
Fri, 05/31/19 - 09:39 am
Adaptive Biotechnologies
IPOs
Genentech
Adaptive Biotechnologies Files for $230 Million IPO
Fri, 05/31/19 - 09:15 am
Adaptive Biotechnologies
Genentech
IPOs
Genmab files for $500M IPO to fund multi-front cancer R&D push
Fierce Biotech
Wed, 05/29/19 - 10:02 am
Genmab
IPOs
antibody-drug conjugate
cervical cancer
New IPO filings include BridgeBio, Dermavant, Prevail, Atreca, Akero
BioCentury
Mon, 05/27/19 - 11:42 pm
IPOs
BridgeBio
Dermavant
Prevail Therapeutics
Atreca
Akero Therapeutics
Pages
« first
‹ previous
…
19
20
21
22
23
24
25
26
27
…
next ›
last »